News

BIONTO received R&D funding of EUR 1.1 million from Business Finland

13.01.2025

What a start to the year!

Business Finland, a Finnish government organization for innovation funding, has granted BIONTO an R&D funding of EUR 1.1 million. This financial support, together with the previously granted DTA funding, enables BIONTO’s operations to grow in accordance with the business plan. BIONTO has had so many value-added discussions and has received so much guidance from Business Finland, even before the company was founded. Thank you, Business Finland!

IONTO Ltd a Deep Tech Accelerator (DTA) funding

BIONTO received Deep Tech Accelerator funding from Business Finland

10.12.2024

Business Finland, a Finnish government organization for innovation funding, has granted BIONTO Ltd a Deep Tech Accelerator (DTA) funding of EUR 400 000.

We thank Business Finland for the support with this funding decision and throughout our business journey. This DTA grant enables us to build BIONTOs brand, promote marketing and sales, and further develop the business.

We want to use this opportunity to congratulate the other recipients of DTA funding as well.”

For Finnish customers – Business Finland

BIONTO Ltd, a provider of industrial biosolutions, has signed on a capital investment of EUR 4 million.

27.08.2024

BIONTO Ltd closed its funding round by signing an investment agreement of EUR 4 million with Korpi Capital and welcomed the new partner to the Board.

“The signed investment agreement enables our operational business and ensures the company’s growth, and we would like to sincerely thank Korpi Capital for the trust. Korpi Capital will be a valuable and reliable partner for us.“

Loading more

Dr. Marika Alapuranen

Chief Scientist, Founder

I have built my scientific and technological expertise in the development of microbial strains, platforms, and industrial enzymes. My focus has been and continues to be on enabling the efficient, industrially feasible cell-based production of high-quality biological products.

Working as an expert in a highly competent R&D team is rewarding. I believe that success lies in a consistent and structured way of working that supports innovation and growth.

“I’m a team player and enjoy brainstorming together with colleagues. I value trust, authenticity, and openness – supporting individual and organisational growth.“

Dr. Terhi Puranen

CEO, Founder

I have had the privilege of leading highly successful teams in the industrial enzyme business that have developed competitive products for the mass market for 15 years. I have ensured business competitiveness by building an IP portfolio, and most importantly, by providing day-to-day stakeholder/customer support.

It should come as no surprise that technological development also inspires me. I have designed and led strategies, roadmaps and projects in terms of cell-based production platforms, Bio-IT and R&D digitalization.

“I want to be a value-adding leader that foster a culture of trust, collaboration and learning. I believe it enables our customers to reach their full potential and succeed beyond expectations.“

Katja Palmunen

CTO, Founder

My technological foundation is built on the design of industrial crystallization processes for concentrated and purified products ranging from therapeutic proteins to enzymes. I am delighted to have been able to provide R&D services that are trusted by many, including some of the world’s largest pharmaceutical companies.

That decade was just an appetizer. It was followed by a deeper dive into industrial upscaling, particularly enzyme processing and formulation technologies, leading up to hundreds of commercial bulk enzyme products.

”Set a goal. My passion is to design the most high-quality, streamlined and cost-effective process to achieve the given goal.”